Abstract The staging of malignant tumors is a fundamental component of treatment selection, prognosis prediction and academic exchange. As“Chinese 2008 staging for nasopharyngeal carcinoma (NPC)”was widely adopted in China from 2009, more and more coordination and exchange of information has been carried out between treatment centers, which has promoted the development of multicenter clinical trials and staging studies. On July 1, 2017, an expert consensus conference was held by the Chinese Committee for Staging of NPC to discuss the revision of Chinese 2008 staging for NPC in Nanping City, Fujian Province. After a full discussion and communication according to evidence-based medicine, a consensus was made. The 8th edition UICC/AJCC staging system for NPC was more rational because it had incorporated the strengths of the Chinese 2008 and the 7th edition UICC/AJCC staging systems. Chinese 2008 staging should be revised based on the 8th edition UICC/AJCC staging system to make an internationally unified staging system. Therefore, the experts strongly recommended Chinese 2017 staging for NPC should be consistent with the 8th edition UICC/AJCC staging system.
Corresponding Authors:
Pan Jianji,Department of Radiation Oncology,Fujian Cancer Hospital,Affiliated Cancer Hospital of Fujian Medical University,Fuzhou 350014,China;Email:panjianji@126.com
Cite this article:
Chinese Committee for Staging of Nasopharyngeal Carcinoma. The 2017 edition for staging of nasopharyngeal carcinoma in China (The Chinese 2008 expert consensus on staging revision of nasopharyngeal carcinoma)[J]. Chinese Journal of Radiation Oncology, 2017, 26(10): 1119-1124.
Chinese Committee for Staging of Nasopharyngeal Carcinoma. The 2017 edition for staging of nasopharyngeal carcinoma in China (The Chinese 2008 expert consensus on staging revision of nasopharyngeal carcinoma)[J]. Chinese Journal of Radiation Oncology, 2017, 26(10): 1119-1124.
[1] Min H,Hong M,Ma J,et al. A new staging system for nasopharyngeal carcinoma in China[J].Int J Radiat Oncol Biol Phys,1994,30(5):1037-1042. [2] Yi J,Huang X,Li G,et al. Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma[J].Radiat Oncol,2014,9(1):56.DOI:10.1186/1748-717X-9-56. [3] Sun X,Su S,Chen C,et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma:An analysis of survival and treatment toxicities[J].Radiother Oncol,2014,110(3):398-403.DOI:10.1016/j.radonc.2013.10.020. [4] Ng WT,Lee MCH,Chang ATY,et al. The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT[J].Oral Oncol,2014,50(5):506-512.DOI:10.1016/j.oraloncology.2014.01.017. [5] Wang W,Feng M,Fan Z,et al. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J].Biomed ResInt,2014,2014(1):814948.DOI:10.1155/2014/814948. [6] Hung TM,Chen CC,Lin CY,et al. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J].Oral Oncol,2014,50(3):228-233.DOI:10.1016/j.oraloncology.2013.12.005. [7] Zong J,Lin S,Lin J,et al. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma:Validation of the 7th edition AJCC staging system[J].Oral Oncol,2015,51(3):254.DOI:10.1016/j.oraloncology.2014.10.012. [8] 姜锋,胡福军,胡巧英,等.第7版UICC或AJCC鼻咽癌分期的IMRT验证研究[J].中华放射肿瘤学杂志,2015,24(3):281-284.DOI:10.3760/cma.j.issn.1004-4221.2015.03.013. Jiang F,Hu FJ,Hu QY,et al. Evaluation of significance of the 7th edition of the International Union against Cancer/American Joint Committee on Cancer staging system for nasopharyngeal carcinoma with intensity-modulated radiotherapy[J].Chin J Radiat Oncol,2015,24(3):281-284.DOI:10.3760/cma.j.issn.1004-4221.2015.03.013. [9] Ou X,Zhou X,Shi Q,et al. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy:new insight into the value of total dose of cisplatin and radiation boost[J].Oncotarget,2015,6(35):38381-38397.DOI:10.18632/oncotarget.5420. [10] Min K,Long J,Li G,et al. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy:results of a prospective multicentric clinical study[J].Oncotarget,2016,7(12):15252-15261.DOI:10.18632/oncotarget.7553. [11] Webber C,Gospodarowicz M,Sobin LH,et al. Improving the TNM classification:Findings from a 10-year continuous literature review[J].Int J Cancer,2014,135(2):371-378.DOI:10.1002/ijc. 28683. [12] 中国鼻咽癌临床分期工作委员会.鼻咽癌’92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-6.DOI:10.3760/cma.j.issn.1004-4221.2009.01.002. Chinese Committee for Staging of Nasopharyngeal Carcinoma. Report on revision of Chinese′92 Staging of nasopharyngeal carcinoma[J].Chin J Radiat Oncol,2009,18(1):2-6.DOI:DOI:10.3760/cma.j.issn.1004-4221.2009.01.002. [13] Chan NSC,Yen TC.Staging of untreated nasopharyngeal carcinoma with PET-CT:comparison with conventional imaging work-up[J].Eur J Nucl Med Mol Imaging,2009,36(1):12-22.DOI:10.1007/s00259-008-0918-7. [14] Liu WS,Wu MF,Tseng HC,et al. The Role of Pretreatment FDG-PET in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy[J].Int J Radiat Oncol Biol Phys,2012,82(2):561-566.DOI:10.1016/j.ijrobp.2010.11.055. [15] Lee SW,Nam SY,Im KC,et al. Prediction of prognosis using standardized uptake value of 2-[(18) F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas[J].Radiother Oncol,2008,87(2):211-216.DOI:10.1016/j.radonc.2008.01.009. [16] Lee AWM,Au JSK,Teo PML,et al. Staging of nasopharyngeal carcinoma:suggestions for improving the current UICC/AJCC staging system[J].Clin Oncol (R Coll Radiol),2004,16(4):269-276. [17] Low JS,Heng DM,Wee JT.The question of T2a and N3a in the UICC/AJCC (1997) staging system for nasopharyngeal carcinoma[J].Clin Oncol (R Coll Radiol),2004,16(8):581-583. [18] Liu MZ,Tang LL,Zong JF,et al. Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement[J].Int J Radiat Oncol Biol Phys,2008,70(4):1115-1123.DOI:10.1016/j.ijrobp.2007.07.2353. [19] Edge SB,Byrd DR,Compton CC,et al. AJCC cancer staging manual[M].7th ed. Philadelphia:Lippincott-Raven,2009. [20] Pan JJ,Ng WT,Zong JF,et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy[J].Cancer,2016,122(4):546.DOI:10.1002/cncr.29795. [21] 方燕红,陈韵彬,林少俊,等.基于MRI和IMRT的鼻咽癌鼻窦侵犯的预后研究[J].中华放射肿瘤学杂志,2016,25(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2016.01.003. Fang YH,Chen YB,Lin SJ,et al. The prognostic value of paranasal sinus involvement based on MRI in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy[J].Chin J Radiat Oncol,2016,25(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2016.01.003. [22] Ouyang PY,Su Z,Ma XH,et al. Comparison of TNM staging systems for nasopharyngeal carcinoma,and proposal of a new staging system[J].Br J Cancer,2013,109(12):2987-2997.DOI:10.1038/bjc.2013.659. [23] Tang L,Li L,Mao Y,et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging:prognostic value and staging categories[J].Cancer,2008,113(2):347.DOI:10.1002/cncr.23555. [24] Pan J,Xu Y,Qiu S,et al. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma[J].Am J Clin Oncol,2015,38(2):189.DOI:10.1097/COC.0b013e31828f5c96. [25] Tang LL,Guo R,Zhou G,et al. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J/OL].Plos One,2014,9(10):e108375.DOI:10.1371/journal.pone.0108375. [26] Chen L,Mao YP,Xie FY,et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China[J].Radiother Oncol,2012,104(3):331-337.DOI:10.1016/j.radonc.2011.10.00. [27] Li WF,Sun Y,Mao YP,et al. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy[J].Int J Radiat Oncol Biol Phys,2013,86(2):249-256.DOI:10.1016/j.ijrobp.2012.09.003. [28] 毛燕萍,李文斐,陈磊,等.鼻咽癌2008分期的临床验证[J].癌症,2009,28(10):1022-1028.DOI:1000-467X (2009)10-1022-07. Mao YP,Li WF,Chen L,et al. A Clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma[J].Chin J Cancer,2009,28(10):1022-1028.DOI:1000-467X (2009)10-1022-0. [29] Guo Q,Pan J,Zong J,et al. Suggestions for lymph node classification of uicc/ajcc staging system:a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy[J].Medicine,2015,94(20):e808.DOI:10.1097/MD.0000000000000808. [30] Greenberg JS,Fowler R,Gomez J,et al. Extent of extracapsular spread:a critical prognosticator in oral tongue cancer[J].Cancer,2003,97(6):1464-1470. [31] Hirabayashi H,Koshii K,Uno K,et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes:prognostic factor of laryngeal cancer[J].Laryngoscope,1991,101(5):502-506. [32] Mao YP,Liang SB,Liu LZ,et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging[J].Clin Cancer Res,2008,14(22):7497-7503.DOI:10.1158/1078-0432.CCR-08-0271. [33] Kinga AD,Yuen EHY,To EWH,etal. Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes[J].Eur J Radiol,2004,52(3):264-270. [34] Steinkamp HJ,Beck A,Werk M,et al. Extracapsular spread of cervical lymph node metastases:Diagnostic value of magnetic resonance imaging[J].Rofo,2002,174(1):50. [35] 康敏,赵婷婷,周平婷,等.基于IMRT和RTOG颈部淋巴结分区标准的鼻咽癌N分期研究[J].中华放射肿瘤学杂志,2017,26(5):501-507.DOI:10.3760/cma.j.issn.1004-4221.2017.05.004. Kang M,Zhao TT,Zhou PT,et al. Study on N staging system for nasopharyngeal carcinoma based on intensity-modulated radiotherapy and RTOG guidelines for cervical lymph node levels[J].Chin J Radiat Oncol,2017,26(5):501-507.DOI:10.3760/cma.j.issn.1004-4221.2017.05.004. [36] Yue D,Xu YF,Zhang F,et al. Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?[J].Radiother Oncol,2014,113(1):108.DOI:10.1016/j.radonc.2014.08.036. [37] MB A,SB E,FL G.AJCC Cancer Staging Manual[M].8th ed. New York:Springer,2017. [38] Zong J,Lin S,Chen Y,et al. Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?[J/OL].Plos One,2014,9(6):e100571.DOI:10.1371/journal.pone.0100571. [39] Grégoire V,Ang K,Budach W,et al. Delineation of the neck node levels for head and neck tumors:a 2013 update. DAHANCA,EORTC,HKNPCSG,NCIC CTG,NCRI,RTOG,TROG consensus guidelines[J].Radiother Oncol,2014,110(1):172.DOI:10.1016/j.radonc.2013.10.010.
2017, Vol. 26 
